{"title":"The Proportion of Lymphocytes and Eosinophils in Leukocytes as Early Screening Markers for Sepsis: a Mendelian Randomization Analysis.","authors":"Liang-Min Chen, Rong-Yan Han","doi":"10.7754/Clin.Lab.2024.241120","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to explore the potential role of white blood cell components in the early screening of sepsis using Mendelian randomization. The analysis considers five cell types: lymphocytes, monocytes, neutrophils, eosinophils, and basophils.</p><p><strong>Methods: </strong>Relevant genome-wide association study (GWAS) datasets were retrieved from the IEU Open GWAS Project. Subsequently, a two-sample Mendelian randomization (MR) analysis was conducted, with the proportions of the five cell types within white blood cells as the exposure factors and the occurrence of sepsis as the outcome variable. Specifically, Cochran's Q statistic was employed to test heterogeneity, and horizontal pleiotropy of instrumental variable SNPs was examined.</p><p><strong>Results: </strong>The Mendelian randomization analysis indicated that the proportion of lymphocytes may potentially predict the occurrence of sepsis, with a weighted median algorithm yielding an OR (95% CI) of 1.1536 (1.0018 - 1.3284). The proportion of eosinophils may potentially reduce the risk of sepsis, with p-values of 0.0349 and 0.0243 from the IVW and MR-PRESSO algorithms, respectively, and OR (95% CI) values of 0.9273 (0.8645 - 0.9947) and 0.9218 (0.8594 - 0.9888).</p><p><strong>Conclusions: </strong>An increased proportion of lymphocytes and a decreased proportion of eosinophils in white blood cells may serve as potential biological markers for the early detection of sepsis.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 6","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241120","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study aimed to explore the potential role of white blood cell components in the early screening of sepsis using Mendelian randomization. The analysis considers five cell types: lymphocytes, monocytes, neutrophils, eosinophils, and basophils.
Methods: Relevant genome-wide association study (GWAS) datasets were retrieved from the IEU Open GWAS Project. Subsequently, a two-sample Mendelian randomization (MR) analysis was conducted, with the proportions of the five cell types within white blood cells as the exposure factors and the occurrence of sepsis as the outcome variable. Specifically, Cochran's Q statistic was employed to test heterogeneity, and horizontal pleiotropy of instrumental variable SNPs was examined.
Results: The Mendelian randomization analysis indicated that the proportion of lymphocytes may potentially predict the occurrence of sepsis, with a weighted median algorithm yielding an OR (95% CI) of 1.1536 (1.0018 - 1.3284). The proportion of eosinophils may potentially reduce the risk of sepsis, with p-values of 0.0349 and 0.0243 from the IVW and MR-PRESSO algorithms, respectively, and OR (95% CI) values of 0.9273 (0.8645 - 0.9947) and 0.9218 (0.8594 - 0.9888).
Conclusions: An increased proportion of lymphocytes and a decreased proportion of eosinophils in white blood cells may serve as potential biological markers for the early detection of sepsis.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.